表紙
市場調查報告書

生物外科 (生物手術)的全球市場

Biosurgery

出版商 Global Industry Analysts, Inc. 商品編碼 893777
出版日期 內容資訊 英文 139 Pages
商品交期: 最快1-2個工作天內
價格
生物外科 (生物手術)的全球市場 Biosurgery
出版日期: 2020年09月01日內容資訊: 英文 139 Pages
簡介

本報告提供全球生物外科 (生物學的外科治療) 市場相關分析,整體市場規模的成果值、預測值,及主要推動及阻礙市場要素,各產品及各企業的市場佔有率趨勢 (過去9年、今後8年份),今後的市場成長的方向性,各地區、主要國家的市場詳細趨勢等調查,及主要企業的簡介等資訊彙整。

第1章 分析方法

第2章 摘要整理

  • 市場概要
    • 各企業的市場佔有率結構 (最新值、預測值)
    • 各種類的市場佔有率結構 (最新值、預測值)
  • 代表性企業分析
  • 市場趨勢與促進因素
  • 全球市場的未來展望
    • 市場規模、佔有率趨勢預測:各地區/各國
    • 手術用密封材料
      • 市場規模 (過去9年、今後8年份)
      • 市場佔有率:各企業 (總計17年份)
    • 止血劑
    • 粘連防止劑
    • 軟組織管理
    • 替代骨移植片

第3章 市場分析

  • 各地區的市場分析
  • 美國
    • 市場基本資料
    • 各企業市場佔有率
    • 生物外科的市場規模 (成果值、預測值)
    • 各產品的市場規模 (成果值、預測值)
  • 加拿大
  • 日本
  • 中國
  • 歐洲
    • 法國
    • 德國
    • 義大利
    • 英國
    • 其他
  • 亞太地區
  • 其他國家 (RoW)

第4章 企業

  • B. BRAUN MELSUNGEN AG
  • BARD, A BECTON, DICKINSON COMPANY
  • BAXTER INTERNATIONAL
  • COHERA MEDICAL
  • CRYOLIFE
  • HEMOSTASIS
  • INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  • JOHNSON & JOHNSON
  • MAQUET HOLDING B.V. & CO. KG
  • MEDTRONIC PLC
  • PFIZER
  • SANOFI US
  • STRYKER CORPORATION

第5章 相關分析

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: MCP10738

Global Biosurgery Market to Reach $16.7 Billion by 2027

Amid the COVID-19 crisis, the global market for Biosurgery estimated at US$11.8 Billion in the year 2020, is projected to reach a revised size of US$16.7 Billion by 2027, growing at a CAGR of 5.1% over the analysis period 2020-2027. Surgical Sealing Agents, one of the segments analyzed in the report, is projected to record a 5.9% CAGR and reach US$3 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Hemostatic Agents segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $3.5 Billion, While China is Forecast to Grow at 4.8% CAGR

The Biosurgery market in the U.S. is estimated at US$3.5 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$2.9 Billion by the year 2027 trailing a CAGR of 4.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5% and 4% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.1% CAGR.

Anti-Adhesion Agents Segment to Record 5.5% CAGR

In the global Anti-Adhesion Agents segment, USA, Canada, Japan, China and Europe will drive the 5.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$453.4 Million in the year 2020 will reach a projected size of US$661.5 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$1.9 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 139-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • B. Braun Melsungen AG
  • BARD, A Becton, Dickinson Company
  • Baxter International, Inc.
  • Cohera Medical, Inc.
  • CryoLife, Inc.
  • Hemostasis, LLC
  • Integra LifeSciences Holdings Corporation
  • Johnson & Johnson
  • MAQUET Holding B.V. & Co. KG
  • Medtronic PLC
  • Pfizer, Inc.
  • Sanofi U.S.
  • Stryker Corporation

TABLE OF CONTENTS

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Biosurgery Market to Witness Steady Growth
    • Percentage Market Share of Worldwide Bio-Surgeries by Country: 2015 and
    • Bone Graft Substitutes to Account for Largest Share
    • North American Region to Dominate Market Growth
    • Worldwide Biosurgery Market: Breakdown of Total Sales Value (in Billion USD) by Region: 2015 and
    • Global Competitor Market Shares
    • A Prelude into Leading Players
    • Global Biosurgery Market: Percentage Breakdown of Market Shares by Leading Players:
    • Biosurgery Competitor Market Share Scenario Worldwide (in %): 2019 &
    • Impact of Covid-19 and a Looming Global Recession
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • New Approvals to Support Market Growth
    • Various Strategies from Leading Players to Bolster Market Growth
    • Rapid Growth in Ageing Population Drives Market Growth
    • Global Population Statistics and Estimates for the 60+ Age Group (1990, 2015, 2050E, 2100E)
    • Rise in Worldwide Surgical Procedures to Fuel Market Growth
    • Total Number of Surgical Procedures Performed (in Millions) Per Annum in the US: 1981
    • Total Number of Surgical Procedures Performed for Inpatients in Europe per Annum: 2001
    • Rising Incidence of Injuries due to Trauma Supports Market Growth
    • Myriad Health End-Users to Drive Market Growth
    • Percentage Breakdown of Biosurgery Market Shares by Application:
    • Percentage Growth Rate of Various Bio-Surgical Products in Wound-Closure Segment: 2011
    • Innovations to Spur Market Growth
    • Total Sales of DermaPure: 2016
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: Biosurgery Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020
    • TABLE 2: Biosurgery Global Retrospective Market Scenario in US$ Million by Region/Country: 2012
    • TABLE 3: Biosurgery Market Share Shift across Key Geographies Worldwide: 2012 VS 2020 VS
    • TABLE 4: Surgical Sealing Agents (Product) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 5: Surgical Sealing Agents (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 6: Surgical Sealing Agents (Product) Market Share Breakdown of Worldwide Sales by Region/Country: 2012 VS 2020 VS
    • TABLE 7: Hemostatic Agents (Product) Potential Growth Markets Worldwide in US$ Million: 2020 to
    • TABLE 8: Hemostatic Agents (Product) Historic Market Perspective by Region/Country in US$ Million: 2012 to
    • TABLE 9: Hemostatic Agents (Product) Market Sales Breakdown by Region/Country in Percentage: 2012 VS 2020 VS
    • TABLE 10: Anti-Adhesion Agents (Product) Geographic Market Spread Worldwide in US$ Million: 2020 to
    • TABLE 11: Anti-Adhesion Agents (Product) Region Wise Breakdown of Global Historic Demand in US$ Million: 2012 to
    • TABLE 12: Anti-Adhesion Agents (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS
    • TABLE 13: Soft Tissue Management (Product) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to
    • TABLE 14: Soft Tissue Management (Product) Market Historic Review by Region/Country in US$ Million: 2012 to
    • TABLE 15: Soft Tissue Management (Product) Market Share Breakdown by Region/Country: 2012 VS 2020 VS
    • TABLE 16: Bone Graft Substitutes (Product) World Market by Region/Country in US$ Million: 2020 to
    • TABLE 17: Bone Graft Substitutes (Product) Historic Market Analysis by Region/Country in US$ Million: 2012 to
    • TABLE 18: Bone Graft Substitutes (Product) Market Share Distribution in Percentage by Region/Country: 2012 VS 2020 VS

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Biosurgery Market Share (in %) by Company: 2019 &
    • Market Analytics
    • TABLE 19: United States Biosurgery Market Estimates and Projections in US$ Million by Product: 2020 to
    • TABLE 20: Biosurgery Market in the United States by Product: A Historic Review in US$ Million for 2012
    • TABLE 21: United States Biosurgery Market Share Breakdown by Product: 2012 VS 2020 VS
  • CANADA
    • TABLE 22: Canadian Biosurgery Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 23: Canadian Biosurgery Historic Market Review by Product in US$ Million: 2012
    • TABLE 24: Biosurgery Market in Canada: Percentage Share Breakdown of Sales by Product for 2012, 2020, and
  • JAPAN
    • TABLE 25: Japanese Market for Biosurgery: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 26: Biosurgery Market in Japan: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 27: Japanese Biosurgery Market Share Analysis by Product: 2012 VS 2020 VS
  • CHINA
    • TABLE 28: Chinese Biosurgery Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 29: Biosurgery Historic Market Analysis in China in US$ Million by Product: 2012
    • TABLE 30: Chinese Biosurgery Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
  • EUROPE
    • Market Facts & Figures
    • European Biosurgery Market: Competitor Market Share Scenario (in %) for 2019 &
    • Market Analytics
    • TABLE 31: European Biosurgery Market Demand Scenario in US$ Million by Region/Country: 2020
    • TABLE 32: Biosurgery Market in Europe: A Historic Market Perspective in US$ Million by Region/Country for the Period 2012
    • TABLE 33: European Biosurgery Market Share Shift by Region/Country: 2012 VS 2020 VS
    • TABLE 34: European Biosurgery Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 35: Biosurgery Market in Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 36: European Biosurgery Market Share Breakdown by Product: 2012 VS 2020 VS
  • FRANCE
    • TABLE 37: Biosurgery Market in France by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 38: French Biosurgery Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 39: French Biosurgery Market Share Analysis by Product: 2012 VS 2020 VS
  • GERMANY
    • TABLE 40: Biosurgery Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Product for the Period 2020
    • TABLE 41: German Biosurgery Historic Market Analysis in US$ Million by Product: 2012
    • TABLE 42: German Biosurgery Market Share Breakdown by Product: 2012 VS 2020 VS
  • ITALY
    • TABLE 43: Italian Biosurgery Market Growth Prospects in US$ Million by Product for the Period 2020
    • TABLE 44: Biosurgery Historic Market Analysis in Italy in US$ Million by Product: 2012
    • TABLE 45: Italian Biosurgery Market by Product: Percentage Breakdown of Sales for 2012, 2020, and
  • UNITED KINGDOM
    • TABLE 46: United Kingdom Market for Biosurgery: Annual Sales Estimates and Projections in US$ Million by Product for the Period 2020
    • TABLE 47: Biosurgery Market in the United Kingdom: Historic Sales Analysis in US$ Million by Product for the Period 2012
    • TABLE 48: United Kingdom Biosurgery Market Share Analysis by Product: 2012 VS 2020 VS
  • REST OF EUROPE
    • TABLE 49: Rest of Europe Biosurgery Market Estimates and Forecasts in US$ Million by Product: 2020
    • TABLE 50: Biosurgery Market in Rest of Europe in US$ Million by Product: A Historic Review for the Period 2012
    • TABLE 51: Rest of Europe Biosurgery Market Share Breakdown by Product: 2012 VS 2020 VS
  • ASIA-PACIFIC
    • TABLE 52: Biosurgery Market in Asia-Pacific by Product: Estimates and Projections in US$ Million for the Period 2020
    • TABLE 53: Asia-Pacific Biosurgery Historic Market Scenario in US$ Million by Product: 2012
    • TABLE 54: Asia-Pacific Biosurgery Market Share Analysis by Product: 2012 VS 2020 VS
  • REST OF WORLD
    • TABLE 55: Rest of World Biosurgery Market Estimates and Forecasts in US$ Million by Product: 2020 to
    • TABLE 56: Rest of World Biosurgery Historic Market Review by Product in US$ Million: 2012
    • TABLE 57: Biosurgery Market in Rest of World: Percentage Share Breakdown of Sales by Product for 2012, 2020, and

IV. COMPETITION

  • Total Companies Profiled: 46